ERBB4 and polycystic ovary syndrome: Furthermore, a murine model, involving Erbb4 deletion has demonstrated the emergence of various characteristics seen in PCOS patients, specifically disrupted ovulatory cycles with oligomenorrhoea, obesity and impaired oocyte development.